Development of medications for the treatment of opiate and cocaine addictions: issues for the government and private sector
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
National Academy Press
1995
|
| Schlagworte: | |
| Beschreibung: | Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse Includes bibliographical references |
| Beschreibung: | xvii, 250 p. |
| ISBN: | 0309052440 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044106946 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s1995 |||| o||u| ||||||eng d | ||
| 020 | |a 0309052440 |9 0-309-05244-0 | ||
| 035 | |a (ZDB-30-PAD)EBC3376237 | ||
| 035 | |a (ZDB-89-EBL)EBL3376237 | ||
| 035 | |a (OCoLC)923262252 | ||
| 035 | |a (DE-599)BVBBV044106946 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.86/32061 |2 20 | |
| 245 | 1 | 0 | |a Development of medications for the treatment of opiate and cocaine addictions |b issues for the government and private sector |c Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| 264 | 1 | |a Washington, DC |b National Academy Press |c 1995 | |
| 300 | |a xvii, 250 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse | ||
| 500 | |a Includes bibliographical references | ||
| 650 | 4 | |a Drug addiction |x Treatment | |
| 650 | 4 | |a Cocaine abuse |x Treatment | |
| 650 | 4 | |a Substance abuse |x Treatment | |
| 650 | 0 | 7 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Drogentherapie |0 (DE-588)4122122-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cocain |0 (DE-588)4128249-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Opiate |0 (DE-588)4075669-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |D s |
| 689 | 0 | 1 | |a Cocain |0 (DE-588)4128249-8 |D s |
| 689 | 0 | 2 | |a Drogentherapie |0 (DE-588)4122122-9 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Drogenabhängigkeit |0 (DE-588)4138597-4 |D s |
| 689 | 1 | 1 | |a Opiate |0 (DE-588)4075669-5 |D s |
| 689 | 1 | 2 | |a Drogentherapie |0 (DE-588)4122122-9 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Fulco, Carolyn |e Sonstige |4 oth | |
| 700 | 1 | |a Liverman, Catharyn T. |e Sonstige |4 oth | |
| 700 | 1 | |a Earley, Laurence E. |e Sonstige |4 oth | |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029513791 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804177172074594304 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044106946 |
| collection | ZDB-30-PAD |
| ctrlnum | (ZDB-30-PAD)EBC3376237 (ZDB-89-EBL)EBL3376237 (OCoLC)923262252 (DE-599)BVBBV044106946 |
| dewey-full | 616.86/32061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.86/32061 |
| dewey-search | 616.86/32061 |
| dewey-sort | 3616.86 532061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02359nmm a2200541zc 4500</leader><controlfield tag="001">BV044106946</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s1995 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309052440</subfield><subfield code="9">0-309-05244-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3376237</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3376237</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)923262252</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044106946</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.86/32061</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of medications for the treatment of opiate and cocaine addictions</subfield><subfield code="b">issues for the government and private sector</subfield><subfield code="c">Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">National Academy Press</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xvii, 250 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug addiction</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cocaine abuse</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance abuse</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cocain</subfield><subfield code="0">(DE-588)4128249-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Cocain</subfield><subfield code="0">(DE-588)4128249-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Drogenabhängigkeit</subfield><subfield code="0">(DE-588)4138597-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Opiate</subfield><subfield code="0">(DE-588)4075669-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Drogentherapie</subfield><subfield code="0">(DE-588)4122122-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fulco, Carolyn</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liverman, Catharyn T.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Earley, Laurence E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029513791</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV044106946 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:43:51Z |
| institution | BVB |
| isbn | 0309052440 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029513791 |
| oclc_num | 923262252 |
| open_access_boolean | |
| physical | xvii, 250 p. |
| psigel | ZDB-30-PAD |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | National Academy Press |
| record_format | marc |
| spelling | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine Washington, DC National Academy Press 1995 xvii, 250 p. txt rdacontent c rdamedia cr rdacarrier Committee chairman: Laurence E. Earley. - Support for this study was provided by the National Institute on Drug Abuse Includes bibliographical references Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment Drogenabhängigkeit (DE-588)4138597-4 gnd rswk-swf Drogentherapie (DE-588)4122122-9 gnd rswk-swf Cocain (DE-588)4128249-8 gnd rswk-swf Opiate (DE-588)4075669-5 gnd rswk-swf Drogenabhängigkeit (DE-588)4138597-4 s Cocain (DE-588)4128249-8 s Drogentherapie (DE-588)4122122-9 s 1\p DE-604 Opiate (DE-588)4075669-5 s 2\p DE-604 Fulco, Carolyn Sonstige oth Liverman, Catharyn T. Sonstige oth Earley, Laurence E. Sonstige oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment Drogenabhängigkeit (DE-588)4138597-4 gnd Drogentherapie (DE-588)4122122-9 gnd Cocain (DE-588)4128249-8 gnd Opiate (DE-588)4075669-5 gnd |
| subject_GND | (DE-588)4138597-4 (DE-588)4122122-9 (DE-588)4128249-8 (DE-588)4075669-5 |
| title | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_auth | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_exact_search | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_full | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| title_fullStr | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| title_full_unstemmed | Development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, editors ; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Division of Biobehavioral Sciences and Mental Disorders, Institute of Medicine |
| title_short | Development of medications for the treatment of opiate and cocaine addictions |
| title_sort | development of medications for the treatment of opiate and cocaine addictions issues for the government and private sector |
| title_sub | issues for the government and private sector |
| topic | Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment Drogenabhängigkeit (DE-588)4138597-4 gnd Drogentherapie (DE-588)4122122-9 gnd Cocain (DE-588)4128249-8 gnd Opiate (DE-588)4075669-5 gnd |
| topic_facet | Drug addiction Treatment Cocaine abuse Treatment Substance abuse Treatment Drogenabhängigkeit Drogentherapie Cocain Opiate |
| work_keys_str_mv | AT fulcocarolyn developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector AT livermancatharynt developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector AT earleylaurencee developmentofmedicationsforthetreatmentofopiateandcocaineaddictionsissuesforthegovernmentandprivatesector |